Form 4: Atlassian CEO Michael Cannon-Brookes Executes Stock Sales Under 10b5-1 Plan
SEC Form 4 Filing
Atlassian CEO Michael Cannon-Brookes sold shares of Class A Common Stock on April 8, 2025, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Michael Cannon-Brookes, CEO and Co-Founder of Atlassian Corp, executed multiple sales of Class A Common Stock on April 8, 2025.
- The sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on February 8, 2024.
- The transactions involved the disposal of shares held indirectly through a trust (CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust).
- The sales prices ranged from $180.18 to $198.69 per share.
- A total of 7,598 shares were sold on April 8, 2025.
- Following the reported transactions, the number of shares beneficially owned indirectly by Mr. Cannon-Brookes through the trust is 325,868.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating routine stock sales under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.
Industry Context
Sales by insiders are a common occurrence, especially when executed under pre-arranged trading plans like Rule 10b5-1, which allows insiders to sell shares at predetermined times to avoid accusations of trading on material non-public information.
Key Dates
| Date | Description |
|---|---|
| 02/08/2024 | Date of adoption of Rule 10b5-1 trading plan |
| 04/08/2025 | Date of stock sale transactions |
| 04/09/2025 | Date of Form 4 filing |
Keywords
Form 4, Atlassian, TEAM, Cannon-Brookes, Stock Sale, 10b5-1 Plan, Insider Trading, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.